检索

期
标题
作者
卷 29, 编号 11/12 (2022)
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
Pavlova M.
PDF
(Rus)
卷 26, 编号 4 (2019)
Genetic predictors of the pharmacological effects of dipeptidyl peptidase-4 inhibitors and sulfonylureas in patients with type 2 diabetes mellitus
Shorokhova P., Baranov V., Vorokhobina N., Shpilevaya O.
PDF
(Rus)
编号 6 (2013)
GIPOGLIKEMII V PATOGENEZE SERDEChNO-SOSUDISTOGO RISKA
Ruyatkina L., Ruyatkin D., Berezovskaya G.
PDF
(Rus)
编号 3 (2012)
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M., Petunina N., Antsiferov M., Petunina N.
编号 16 (2011)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antciferov M.
卷 29, 编号 11/12 (2022)
Features of the pathogenesis and treatment of diabetes mellitus during the COVID-19 pandemic
Bagriy A., Mikhailichenko E., Prikolota A., Mogilevskaya K.
PDF
(Rus)
卷 27, 编号 12 (2020)
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T., Fadeyev V.
PDF
(Rus)
编号 16 (2012)
Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?
Antsiferov M., Galstyan G.
PDF
(Rus)
编号 7 (2012)
DPP-4 INHIBITORS: TODAY AND TOMORROW. WHAT WE EXPECT FROM INCRETIN-STIMULATING THERAPY?
Antsiferov M., Ametov A., Zilov A., Antsiferov M., Ametov A., Zilov A.
编号 3 (2012)
SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS
Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.
编号 16 (2011)
SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Petunina N., Brashchenkova A., Petunina N., Brashcenkova A.
编号 16 (2016)
Modern approaches to the treatment of patients with type 2 diabetes mellitus
Antsiferov M., Fadeev V., Morgunova T.
PDF
(Rus)
编号 5 (2015)
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.
PDF
(Rus)
编号 7 (2012)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antsiferov M.
编号 5 (2015)
Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa
Mkrtumyan A.
PDF
(Rus)
编号 16 (2013)
Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa
Ametov A.
PDF
(Rus)
编号 5 (2017)
ELDERLY PATIENT WITH TYPE 2 DIABETES MELLITUS: FOCUS ON ALOGLIPTIN
Petunina N., Terekhova A.
PDF
(Rus)
编号 5 (2014)
ISSLEDOVANIE SAVOR: OTKRYTIE NOVOY EPOKhI BEZOPASNOY FARMAKOTERAPII SAKhARNOGO DIABETA 2 TIPA
Yuryatin A.
PDF
(Rus)
编号 16 (2010)
POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY
Antsiferov M., Zilov A., Antsiferov M., Zilov A.
编号 11 (2018)
Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use
Biryukova E.
PDF
(Rus)
编号 5 (2016)
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
Antsiferov M.
PDF
(Rus)
编号 3 (2011)
CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS
Antsiferov M., Antsiferov M.
卷 29, 编号 11/12 (2022)
Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review
Petunina N., Martirosyan N., Valeeva F.
PDF
(Rus)
卷 26, 编号 14 (2019)
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O., Goloborodova I.
PDF
(Rus)
编号 5 (2016)
GLYCEMIC VARIABILITY AS A THERAPEUTIC TARGET IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
Ametov A., Chernikova N., Demidova T., Nazhmutdinova P.
PDF
(Rus)
编号 20 (2012)
Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov
Ruyatkina L., Sorokin M.
PDF
(Rus)
编号 3 (2012)
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M., Antsiferov M.
编号 16 (2011)
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M., Antciferov M.
1 - 28 的 28 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##